6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To investigate the growth inhibition effect of the combination of bcr/abl phosphorothioate antisense oligonucleotides (PS-ASODN) and curcumin (cur), and the possible mechanisms of cur on the chronic myelogenous leukemia cell line K562.

          Related collections

          Author and article information

          Journal
          Acta Pharmacol Sin
          Acta pharmacologica Sinica
          Wiley
          1671-4083
          1671-4083
          Jan 2007
          : 28
          : 1
          Affiliations
          [1 ] Institute of Clinical Pharmacology, School of Pharmacy, Fujian Medical University, Fujian 350004, China. xjh@mail.fjmu.edu.cn.
          Article
          10.1111/j.1745-7254.2007.00471.x
          17184589
          5bf314ec-6578-432e-a257-aea6efe40584
          History

          Comments

          Comment on this article